Skip to main content

Keenova Therapeutics plc

MNKTQDelisted Sep 6, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001567892

Keenova Therapeutics plc was delisted on Sep 6, 2023; its insiders filed their last Form 4 on Nov 12, 2026; 36 institutions reported holding it in 13F filings for Q2 2023, worth $12.4M in total; no superinvestor held it.

Holders of 5% or more of MNKTQ

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Keenova Therapeutics plc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MNKTQ
HolderLatest formStakeChangeFirst filedLatest filingFiling
Goldentree Asset Management LP13D/A22.40%8.88M shares+1.10 ppfrom 21.30%Dec 13, 20235 filingsNov 10, 2026SEC
Silver Point Capital L.P.13D/A15.20%6.04M shares+1.00 ppfrom 14.20%Nov 24, 20238 filingsMay 22, 2026SEC
Marathon Asset Management LP13G/A6.80%2.71M shares−0.90 ppfrom 7.70%Feb 6, 20244 filingsMay 15, 2026SEC
Hein Park Capital Management LP13G5.50%2.15M shares+0.60 ppfrom 4.90%Jan 17, 20247 filingsFeb 13, 2026SEC
Hudson Bay Capital Management LP13G/A5.19%2.05M shares−1.11 ppfrom 6.30%Feb 9, 20235 filingsFeb 11, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

70 Schedule 13D and 13G filings on Keenova Therapeutics plc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MNKTQ
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 10, 20264:57 PM ETGoldentree Asset Management LPand 3 others13D/A22.40%8.88M shares+1.10 ppfrom 21.30%Nov 6, 2026SEC
Oct 6, 20264:30 PM ETGoldentree Asset Management LPand 2 others13D/A21.30%8.44M shares+1.10 ppfrom 20.20%Sep 24, 2026SEC
May 22, 20264:05 PM ETSilver Point Capital L.P.and 2 others13D/A15.20%6.04M shares+1.00 ppfrom 14.20%May 20, 2026SEC
May 15, 20264:15 PM ETMarathon Asset Management LPand 3 others13G/A6.80%2.71M shares−0.90 ppfrom 7.70%Mar 31, 2026SEC
Apr 17, 20265:41 PM ETSilver Point Capital L.P.and 2 others13D/A14.20%5.64M shares+2.30 ppfrom 11.90%Apr 15, 2026SEC
Feb 13, 20266:15 PM ETHein Park Capital Management LPand 2 others13G5.50%2.15M shares+0.60 ppfrom 4.90%Dec 31, 2025SEC
Feb 11, 20261:20 PM ETHudson Bay Capital Management LPand 1 other13G/A5.19%2.05M shares−1.11 ppfrom 6.30%Dec 31, 2025SEC
Dec 10, 20256:29 PM ETSilver Point Capital L.P.and 2 others13D/A11.90%4.70M shares+1.20 ppfrom 10.70%Dec 8, 2025SEC
Nov 14, 20254:05 PM ETMarathon Asset Management LPand 12 others13G/A7.70%3.03M shares–Sep 30, 2025SEC
Nov 5, 20257:58 PM ETSilver Point Capital L.P.and 2 others13D/A10.70%4.21M shares+2.10 ppfrom 8.60%Nov 3, 2025SEC
Aug 7, 20254:50 PM ETGoldentree Asset Management LPand 2 others13D20.20%7.95M shares–Jul 31, 2025SEC
Aug 7, 20252:11 PM ETHudson Bay Capital Management LPand 1 other13G/A6.30%2.48M shares–Jul 31, 2025SEC
Aug 4, 20254:52 PM ETHein Park Capital Management LPand 2 others13D/A4.90%1.96M shares−4.79 ppfrom 9.69%Below 5%Jul 31, 2025SEC
May 13, 20258:49 PM ETFlynn James Eand 5 others13G/A4.07%804.3K shares–Below 5%Mar 31, 2025SEC
Mar 18, 20258:02 PM ETSilver Point Capital L.P.and 2 others13D/A8.60%1.69M shares–Mar 13, 2025SEC
Mar 17, 20257:14 PM ETHein Park Capital Management LPand 2 others13D/A9.69%1.91M shares–Mar 13, 2025SEC
Nov 21, 2024Bracebridge Capital, LLC13D/AOld format–––SEC
Nov 14, 2024Flynn James E13G/AOld format–––SEC
Oct 21, 2024Hudson Bay Capital Management LP13G/AOld format–––SEC
Aug 27, 2024Marathon Asset Management LP13G/AOld format–––SEC
Jul 8, 2024Silver Point Capital L.P.13D/AOld format–––SEC
Jun 26, 2024Hein Park Capital Management LP13D/AOld format–––SEC
Jun 18, 2024Goldentree Asset Management LP13G/AOld format–––SEC
Apr 8, 2024Hein Park Capital Management LP13D/AOld format–––SEC
Mar 15, 2024Squarepoint Ops LLC13D/AOld format–––SEC
Mar 11, 2024Hein Park Capital Management LP13D/AOld format–––SEC
Feb 14, 2024Alta Fundamental Advisers LLC13G/AOld format–––SEC
Feb 14, 2024Sculptor Capital LP13G/AOld format–––SEC
Feb 14, 2024Sculptor Capital LP13G/AOld format–––SEC
Feb 14, 2024Continental General Insurance Co13G/AOld format–––SEC
Feb 12, 2024Flynn James E13G/AOld format–––SEC
Feb 6, 2024Hudson Bay Capital Management LP13G/AOld format–––SEC
Feb 6, 2024Marathon Asset Management LP13GOld format–New–SEC
Jan 22, 2024Silver Point Capital L.P.13D/AOld format–––SEC
Jan 17, 2024Hein Park Capital Management LP13DOld format–New–SEC
Jan 4, 2024JPMorgan Chase & Co13G/AOld format–––SEC
Dec 13, 2023Goldentree Asset Management LP13GOld format–New–SEC
Nov 24, 2023Silver Point Capital L.P.13DOld format–New–SEC
Nov 24, 2023Squarepoint Ops LLC13DOld format–New–SEC
Nov 20, 2023Flynn James E13GOld format–New–SEC
Nov 17, 2023Bracebridge Capital, LLC13D/AOld format–––SEC
Aug 25, 2023Bracebridge Capital, LLC13D/AOld format–––SEC
Jun 16, 2023Alta Fundamental Advisers LLC13DOld format–––SEC
Jun 16, 2023Bracebridge Capital, LLC13DOld format–––SEC
Jun 9, 20238:35 AM ETFederated Hermes, Inc.13G/AOld format–––SEC
May 30, 2023Alta Fundamental Advisers LLC13GOld format–New–SEC
May 30, 2023Continental General Insurance Co13GOld format–New–SEC
Feb 14, 2023Sculptor Capital LP13G/AOld format–––SEC
Feb 14, 2023Millstreet Capital Management LLC13GOld format–New–SEC
Feb 9, 2023Hudson Bay Capital Management LP13GOld format–New–SEC

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell Keenova Therapeutics plc shares, newest first.

Form 144 notices for MNKTQ
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Nov 28, 20236:11 PM ETSilver Point Capital L.P.Director130.0K$5.00MNov 15, 2023Jefferies LLCSEC